Is Infantile Inflammatory Bowel Disease Curable with Hematopoietic Stem Cell Transplantation?.
The Korean Journal of Gastroenterology.2013;62(5):313-314. doi:10.4166/kjg.2013.62.5.313
The Korean Journal of Gastroenterology
to Present ISSN: 1598-9992
Sort by
DISPLAY OPTIONS
Format:
Per page:
The Korean Journal of Gastroenterology.2013;62(5):310-312. doi:10.4166/kjg.2013.62.5.310
No abstract available.
Aged ; Constriction, Pathologic ; Diagnosis, Differential ; Female ; Humans ; Jejunum/pathology ; Mesenteric Artery, Superior/*pathology/radiography/surgery ; Stents ; Superior Mesenteric Artery Syndrome/diagnosis/radiography ; Thrombosis/radiography/surgery ; Tomography, X-Ray Computed
Aged ; Constriction, Pathologic ; Diagnosis, Differential ; Female ; Humans ; Jejunum/pathology ; Mesenteric Artery, Superior/*pathology/radiography/surgery ; Stents ; Superior Mesenteric Artery Syndrome/diagnosis/radiography ; Thrombosis/radiography/surgery ; Tomography, X-Ray Computed
A Case of Acute Pancreatitis and Acute Hepatitis Caused by Ingestion of Ceramium kondoi.
The Korean Journal of Gastroenterology.2013;62(5):306-309. doi:10.4166/kjg.2013.62.5.306
In Korea, the use of herbal remedies is a common cause of drug-induced liver injury. However, the occurrence of both acute pancreatitis and acute hepatitis after taking herbal remedies has rarely been reported. Herein, we report a case of concurrent acute pancreatitis and acute hepatitis associated with Ceramium kondoi ingestion. A 58-year-old woman was diagnosed with advanced gastric cancer 7 months ago. Total gastrectomy and adjuvant chemotherapy was performed without complications. The patient had been well until recently, when she presented with severe abdominal pain after ingestion of Ceramium kondoi for 4 weeks. The laboratory findings demonstrated elevated liver enzymes and lipase, and abdominal computed tomography revealed pancreas swelling with fat infiltration. The diagnosis was made based on the diagnostic criteria for drug induced pancreatitis and the Russel Uclaf Causality Assessment Method scale for drug-induced liver injury. After cessation of Ceramium kondoi, she showed clinical and biochemical improvement.
Abdominal Pain/etiology ; Acute Disease ; Drug-Induced Liver Injury/*diagnosis/enzymology ; Female ; Humans ; Lipase/metabolism ; Liver/*drug effects ; Middle Aged ; Pancreas/*drug effects ; Pancreatitis/*chemically induced/*diagnosis ; Plant Extracts/chemistry/*toxicity ; Rhodophyta/chemistry/metabolism ; Tomography, X-Ray Computed
Abdominal Pain/etiology ; Acute Disease ; Drug-Induced Liver Injury/*diagnosis/enzymology ; Female ; Humans ; Lipase/metabolism ; Liver/*drug effects ; Middle Aged ; Pancreas/*drug effects ; Pancreatitis/*chemically induced/*diagnosis ; Plant Extracts/chemistry/*toxicity ; Rhodophyta/chemistry/metabolism ; Tomography, X-Ray Computed
A Case of Small Cell Neuroendocrine Tumor Occurring at Hilar Bile Duct.
The Korean Journal of Gastroenterology.2013;62(5):301-305. doi:10.4166/kjg.2013.62.5.301
Neuroendocrine tumors of the extrahepatic biliary tree are extremely rare malignancies accounting for 0.2-2.0% of all gastrointestinal carcinoid tumors. Neuroendocrine tumors obstructing the biliary tree are extremely difficult to diagnose preoperatively and nearly impossible to differentiate from cholangiocarcinoma. Statistically, the most common anatomic location in the biliary tree is the common bile duct, followed by the perihilar region. Herein, we present a case of a small cell neuroendocrine carcinoma of the hilum in a 79-year-old man following laparotomy. To our knowledge, this is the first case of small cell type neuroendocrine carcinoma of hilar bile duct reported in Korea.
Aged ; Bile Duct Neoplasms/*diagnosis/pathology/surgery ; Cholangiopancreatography, Endoscopic Retrograde ; Diagnosis, Differential ; Hepatic Duct, Common/pathology ; Humans ; Male ; Neuroendocrine Tumors/*diagnosis/pathology/surgery ; Tomography, X-Ray Computed
Aged ; Bile Duct Neoplasms/*diagnosis/pathology/surgery ; Cholangiopancreatography, Endoscopic Retrograde ; Diagnosis, Differential ; Hepatic Duct, Common/pathology ; Humans ; Male ; Neuroendocrine Tumors/*diagnosis/pathology/surgery ; Tomography, X-Ray Computed
A Case of Traumatic Inferior Mesenteric Arteriovenous Fistula.
The Korean Journal of Gastroenterology.2013;62(5):296-300. doi:10.4166/kjg.2013.62.5.296
Inferior mesenteric arteriovenous fistula is rare and may be congenital or acquired. Affected patients present with abdominal pain, mass, or manifestations of portal hypertension and bowel ischemia. Until now, inferior mesenteric arteriovenous fistula due to trauma has not been reported. Herein, we report a case of a 53-year-old woman who had inferior mesenteric arteriovenous fistula considered to have originated from remote blunt trauma that was successfully treated by surgical resection of only the arteriovenous fistula without colectomy. To our knowledge, this is the first case of traumatic inferior mesenteric arteriovenous fistula.
Arteriovenous Fistula/*diagnosis/pathology/surgery ; Colonoscopy ; Female ; Humans ; Mesenteric Artery, Inferior/radiography ; Middle Aged ; Tomography, X-Ray Computed ; Treatment Outcome
Arteriovenous Fistula/*diagnosis/pathology/surgery ; Colonoscopy ; Female ; Humans ; Mesenteric Artery, Inferior/radiography ; Middle Aged ; Tomography, X-Ray Computed ; Treatment Outcome
Herpes Simplex Virus Duodenitis Accompanying Crohn's Disease.
The Korean Journal of Gastroenterology.2013;62(5):292-295. doi:10.4166/kjg.2013.62.5.292
Herpes simplex virus (HSV) is a recognized cause of gastrointestinal infection in immunodeficient patients. Although a few cases of HSV gastritis and colitis in immunocompromised patients have been reported, there are no reports of HSV duodenitis in patients with Crohn's disease (CD). A 74-year-old female was admitted with general weakness and refractory epigastric pain. She had been diagnosed with CD three years ago. Esophagogastroduodenoscopy (EGD) revealed diffuse edematous and whitish mucosa with multiple erosions in the duodenum. Considering the possibility of viral co-infection, cytomegalovirus (CMV) immunohistochemical staining, PCR, and cultures of duodenal biopsies were performed, all of which were negative with the exception of the isolation of HSV in culture. After administration of intravenous acyclovir for 1 week, follow-up EGD showed almost complete resolution of the lesions and the patient's symptoms improved. In CD patients with refractory gastrointestinal symptoms, HSV, as well as CMV, should be considered as a possible cause of infection, so that the diagnosis of viral infection is not delayed and the appropriate antiviral treatment can be initiated.
Acyclovir/therapeutic use ; Aged ; Antiviral Agents/therapeutic use ; Crohn Disease/complications/*diagnosis/virology ; DNA, Viral/analysis ; Duodenitis/complications/*diagnosis ; Endoscopy, Digestive System ; Female ; Herpes Simplex/*diagnosis/drug therapy/virology ; Humans ; Intestinal Mucosa/pathology ; Polymerase Chain Reaction ; Simplexvirus/genetics/*isolation & purification
Acyclovir/therapeutic use ; Aged ; Antiviral Agents/therapeutic use ; Crohn Disease/complications/*diagnosis/virology ; DNA, Viral/analysis ; Duodenitis/complications/*diagnosis ; Endoscopy, Digestive System ; Female ; Herpes Simplex/*diagnosis/drug therapy/virology ; Humans ; Intestinal Mucosa/pathology ; Polymerase Chain Reaction ; Simplexvirus/genetics/*isolation & purification
The Korean Journal of Gastroenterology.2013;62(5):288-291. doi:10.4166/kjg.2013.62.5.288
BACKGROUND/AIMS: Calprotectin is a 36.5 kD calcium and zinc binding protein in the S100 protein family. Fecal calprotectin levels are elevated in patients with inflammatory bowel disease and some other gastrointestinal disorders such as colorectal carcinoma. We decided to evaluate the fecal calprotectin level to see if it was able to distinguish between functional and organic causes of constipation. METHODS: Seventy-six children aged 1 to 120 months that all underwent deep rectal mucosa biopsies at Children Medical Center from November 2010 till September 2011 were recruited. Nineteen cases were diagnosed as Hirschsprung's disease and 57 of the patients had nerve ganglion cells in their biopsies. Calprotectin concentration was analyzed by the ELISA method. RESULTS: Although there was a significant difference between the median of the two groups (p=0.036), the median was not above the predetermined cutoff value of 50 microg/g. CONCLUSIONS: We propose that fecal calprotectin, using the above cutoff value, has limited value in differentiating functional constipation from Hirschsprung's disease.
Age Factors ; Child ; Child, Preschool ; Constipation/*diagnosis ; Diagnosis, Differential ; Enzyme-Linked Immunosorbent Assay ; Feces/chemistry ; Female ; Hirschsprung Disease/*diagnosis/metabolism/pathology ; Humans ; Infant ; Infant, Newborn ; Intestinal Mucosa/pathology ; Leukocyte L1 Antigen Complex/*analysis ; Male ; Sex Factors
Age Factors ; Child ; Child, Preschool ; Constipation/*diagnosis ; Diagnosis, Differential ; Enzyme-Linked Immunosorbent Assay ; Feces/chemistry ; Female ; Hirschsprung Disease/*diagnosis/metabolism/pathology ; Humans ; Infant ; Infant, Newborn ; Intestinal Mucosa/pathology ; Leukocyte L1 Antigen Complex/*analysis ; Male ; Sex Factors
The Korean Journal of Gastroenterology.2013;62(5):278-287. doi:10.4166/kjg.2013.62.5.278
BACKGROUND/AIMS: Antispasmodic agents have been used in the management of irritable bowel syndrome. However, systematic reviews have come to different conclusions about the efficacy in irritable bowel syndrome. Fenoverine acts as a synchronizer of smooth muscle in modulating the intracellular influx of calcium. We compared fenoverine with trimebutine for the treatment of patients with IBS. METHODS: A multicenter, randomized, double-blind, non-inferiority clinical study was conducted to compared fenoverine with trimebutine. Subjects were randomized to receive either fenoverine (100 mg three times a day) or trimebutine (150 mg three times a day) for 8 weeks. A total of 197 patients were analyzed by the intention-to-treat approach. The primary endpoint was the proportion of patients who had 30% reduction in abdominal pain or discomfort measured by bowel symptom scale (BSS) score at week 8 compared to the baseline. The secondary endpoints were changes of abdominal bloating, diarrhea, constipation, overall and total scores of BSS, and overall satisfaction. RESULTS: At week 8, fenoverine was shown to be non-inferior to trimebutine (treatment difference, 1.76%; 90% CI, -10.30-13.82; p=0.81); 69.23% (54 of 78 patients) of patients taking fenoverine and 67.47% (56 of 83 patients) of patients taking trimebutine showed 30% reduction in abdominal pain or discomfort compared to the baseline. There results of the secondary endpoints were also comparable between the fenoverine group and the trimebutine group. CONCLUSIONS: Fenoverine is non-inferior to trimebutine for treating IBS in terms of both efficacy and tolerability.
Abdominal Pain/etiology ; Adult ; Constipation/etiology ; Diarrhea/etiology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Irritable Bowel Syndrome/complications/*drug therapy ; Male ; Middle Aged ; Parasympatholytics/*therapeutic use ; Phenothiazines/*therapeutic use ; Severity of Illness Index ; Treatment Outcome ; Trimebutine/*therapeutic use
Abdominal Pain/etiology ; Adult ; Constipation/etiology ; Diarrhea/etiology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Irritable Bowel Syndrome/complications/*drug therapy ; Male ; Middle Aged ; Parasympatholytics/*therapeutic use ; Phenothiazines/*therapeutic use ; Severity of Illness Index ; Treatment Outcome ; Trimebutine/*therapeutic use
The Korean Journal of Gastroenterology.2013;62(5):272-277. doi:10.4166/kjg.2013.62.5.272
BACKGROUND/AIMS: Gastric lymphoepithelioma-like carcinoma (LLC) is a rare cancer that presents with a unique histologic pattern that is characterized by poorly differentiated malignant cells infiltrating the background stroma along with massive lymphocyte infiltration. Many studies have shown that gastric LLC is associated with better prognosis than other gastric malignancies. However, the reason for better prognosis has not been clarified and the underlying mechanism remains to be elucidated. Therefore, we attempted to determine the clinical characteristics of gastric LLC and identify its prognostic factors related to improved survival. METHODS: A total of 18 patients were diagnosed with gastric LLC after resection from 2005 to 2012 at Department of Gastroenterology in Chungnam National University Hospital. The data of these patients were compared with 36 age- and sex-matched patients with poorly differentiated gastric adenocarcinoma who also underwent resection during the same study period. RESULTS: Postoperative recurrence or metastasis tended to occur less frequent in gastric LLC than in poorly-differentiated gastric adenocarcinoma. Among prognostic factors, only the number of lymph node metastases showed significant difference, with gastric LLC being associated with a smaller number of lymph node metastases. Regarding the disease free and overall survival rate, both were higher for gastric LLC than for poorly-differentiated gastric adenocarcinoma, albeit not statistically significant (p=0.089 and p=0.159, respectively). CONCLUSIONS: Poorly differentiated gastric adenocarcinoma was associated with a higher number of lymph node metastases at diagnosis than gastric LCC. Other potential factors affecting prognosis were not significantly different between the two cancer types.
Adenocarcinoma/*diagnosis/mortality/pathology ; Aged ; Aged, 80 and over ; Carcinoma/diagnosis/mortality/pathology ; Female ; Follow-Up Studies ; Gastrectomy ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Recurrence ; Stomach Neoplasms/*diagnosis/mortality/pathology ; Survival Rate
Adenocarcinoma/*diagnosis/mortality/pathology ; Aged ; Aged, 80 and over ; Carcinoma/diagnosis/mortality/pathology ; Female ; Follow-Up Studies ; Gastrectomy ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Recurrence ; Stomach Neoplasms/*diagnosis/mortality/pathology ; Survival Rate
The Korean Journal of Gastroenterology.2013;62(5):267-271. doi:10.4166/kjg.2013.62.5.267
BACKGROUND/AIMS: Conventional triple therapy (CT) for Helicobacter pylori infection fails in up to one-third of patients. Sequential therapy (ST) seem be more effective than CT in other countries. However, there is no systemic literature review that directly compares CT and ST in Korea. The aim of this study was to compare ST with CT for H. pylori infection in Korea. METHODS: Six randomized, prospective controlled trials were used to compare 10-day ST and 7- to 14-day CT in treatment-naive patients with documented H. pylori infection in Korea. Pooled eradication rates and OR with 95% CI were calculated. RESULTS: The intention-to-treat eradication rates of H. pylori involving 1,529 patients were 79.7% (95% CI, 76.8-82.5%) for ST (n=754) and 68.1% (95% CI, 64.8-71.4%) for CT (n=775) (OR, 1.838; p<0.001). The per-protocol eradication rate of H. pylori involving 1,366 patients was 86.4% (95% CI, 83.3-88.5%) for ST (n=682) and 76.0% (95% CI, 72.8-79.2%) for CT (n=684) (OR, 1.974; p<0.001). CONCLUSIONS: Ten-day ST was superior to CT in terms of eradicating H. pylori infection. Therefore, ST should be considered as a first-line therapy in Korea. However, ST did not achieve a sufficient eradication rate. More effective therapy should be developed.
Anti-Bacterial Agents/*therapeutic use ; Databases, Factual ; Drug Therapy, Combination ; Helicobacter Infections/*drug therapy ; *Helicobacter pylori ; Humans ; Odds Ratio ; Prospective Studies ; Republic of Korea ; Treatment Outcome
Anti-Bacterial Agents/*therapeutic use ; Databases, Factual ; Drug Therapy, Combination ; Helicobacter Infections/*drug therapy ; *Helicobacter pylori ; Humans ; Odds Ratio ; Prospective Studies ; Republic of Korea ; Treatment Outcome
Country
Republic of Korea
Publisher
Korean Society of Gastroenterology
ElectronicLinks
http://www.kjg.or.kr/Editor-in-chief
Abbreviation
Korean J Gastroenterol
Vernacular Journal Title
대한소화기학회지
ISSN
1598-9992
EISSN
2233-6869
Year Approved
2007
Current Indexing Status
Currently Indexed
Start Year
Description
Previous Title
Powered by IMICAMS(
备案号: 11010502037788, 京ICP备10218182号-8)